Pharmacy Program

The Power of Your Choice

Your choice of the IHTC Pharmacy Program directly supports your IHTC team and patient services, and activities provided to the hemophilia community. The IHTC Pharmacy Program provides savings to you and your health insurance plan.

Every patient has the right to choose their clotting factor pharmacy provider. The IHTC supports your right of choice and will assist you in making an informed decision.

Anticoagulation Clinic

People who are regularly seen in an anticoagulation (blood thinning) clinic have fewer episodes of major bleeding and recurrent blood clots compared with patients who receive care outside of these specialty clinics.1-5 These improved outcomes are likely a result of a multidisciplinary approach, which involves close follow-up with care providers and more frequent monitoring of therapy.

The IHTC’s anticoagulation clinic uses a multidisciplinary comprehensive approach for treatment of patients on blood thinning therapy (e.g., warfarin [Coumadin®] or low molecular weight heparin). The anticoagulation clinic is led by physician assistants experienced in the treatment of clotting (thrombotic) disorders. A board certified hematologist is available on-site as needed. Each patient’s medical status is reviewed with a hematologist after the anticoagulation clinic visit. Anticoagulation clinic staff are supported as needed by the IHTC’s physical therapist (for strengthening exercise therapy, especially involving clot-related pain and leg swelling), registered dietitian, genetic counselor, and social worker (largely involving insurance coverage counseling). Visit our Meet the Staff section to learn more about the IHTC’s professionals.

Patients using blood thinning therapy are seen at least every 6 months in the anticoagulation clinic. In clinic, patients receive education about blood thinning therapy and are monitored for food and drug interactions with their particular blood thinner. Patients also receive information on their specific inherited or acquired clotting disorder, if relevant. Moreover, the clinic professionals offer counseling to help patients manage their symptoms. Periodically additional laboratory tests may be needed, either to monitor the effectiveness of therapy or to provide additional information related to risk factors. Some laboratory studies may be ordered to detect early signs of complications and side effects and to help prevent them.

The IHTC’s anticoagulation clinic is held weekly. For more information about the clinic, contact the center at 317.871.0000 (toll free 1-877-CLOTTER [877-256-8837]).


  1. Jones C, Lacombe G. Enhancing patient care via a pharmacist-managed rural anticoagulation clinic. Health Q. 2009;Oct;13 Spec No:69-74.
  2. Bungard TJ, Gardner L, Archer SL, et al. Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care. Open Med. 2009;3:16-21.
  3. Nichol MB, Knight TK, Dow T, Wygant G, et al. Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care. Ann Pharmacother. 2008;42:62-70.
  4. Francavilla CL. Registered nurse-managed anticoagulation clinic: improving patient outcomes. Nurs Econ. 2008;26:130-132.
  5. Nochowitz B, Shapiro NL, Nutescu EA, et al. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population. Ann Pharmacother. 2009;43:1165-72.
Did you like this? Share it: